ANTB
IDXG

AMG National Trust Bank’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

AMG National Trust Bank’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-219
Closed -$39K – 277
2015
Q3 		$39K Buy
219
+69
+46% +$13.6K ﹤0.01% 255
2015
Q2 		$22K Hold
150
– – ﹤0.01% 249
2015
Q1 		$20K Hold
150
– – ﹤0.01% 243
2014
Q4 		$27K Hold
150
– – ﹤0.01% 249
2014
Q3 		$36K Buy
+150
New +$50.1K ﹤0.01% 240

Other funds holding IDXG

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AMG National Trust Bank's IDXG Position: Q4 2015 in Review

AMG National Trust Bank sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q4 2015, closing a stake of 219 shares — an estimated $39K sold.

AMG National Trust Bank first reported a position in IDXG in Q3 2014 and held it in 5 quarters. The position peaked at $39K in Q3 2015. 19 funds tracked by Wall St. Rank hold IDXG as of Q4 2015.

  • AMG National Trust Bank reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • AMG National Trust Bank sold 219 Interpace Biosciences, Inc. Common Stock shares in Q4 2015, an estimated $39K.
  • AMG National Trust Bank first reported a position in Interpace Biosciences, Inc. Common Stock in Q3 2014 and held it in 5 quarters.
  • AMG National Trust Bank's Interpace Biosciences, Inc. Common Stock position peaked at $39K in Q3 2015.
  • 19 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q4 2015.

Based on AMG National Trust Bank's 13F filing for Q4 2015, filed 8 Feb 2016.